1. Home
  2. DEI vs CPRX Comparison

DEI vs CPRX Comparison

Compare DEI & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$9.25

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$24.79

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
CPRX
Founded
1971
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.9B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
DEI
CPRX
Price
$9.25
$24.79
Analyst Decision
Hold
Strong Buy
Analyst Count
8
1
Target Price
$13.19
$35.00
AVG Volume (30 Days)
2.3M
897.2K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
8.07%
N/A
EPS Growth
N/A
28.24
EPS
0.09
1.68
Revenue
$1,003,982,000.00
$119,072,803.00
Revenue This Year
$2.29
$9.20
Revenue Next Year
$2.04
$10.51
P/E Ratio
$104.78
$14.75
Revenue Growth
1.77
16.39
52 Week Low
$9.12
$19.05
52 Week High
$16.94
$26.56

Technical Indicators

Market Signals
Indicator
DEI
CPRX
Relative Strength Index (RSI) 38.60 58.27
Support Level N/A $22.24
Resistance Level $10.18 $24.94
Average True Range (ATR) 0.32 0.66
MACD -0.00 0.18
Stochastic Oscillator 16.51 89.26

Price Performance

Historical Comparison
DEI
CPRX

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: